echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Cell: MIT research discovers new targets for future cancer vaccines

    Cell: MIT research discovers new targets for future cancer vaccines

    • Last Update: 2021-10-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Targeting specific proteins found on cancer cells, vaccines can help enhance the response of T cells to tumors


    For the past decade, scientists have been exploring vaccines to help fight cancer


    So far, none of these vaccines have been approved by the FDA, but some vaccines have shown promise in the treatment of melanoma and certain types of lung cancer in clinical trials


    The research team found that vaccines targeting the types of proteins they identified can help awaken the population of dormant T cells that target these proteins and strengthen the overall immune response


    "This study emphasizes the importance of in-depth exploration of the details of the anti-cancer immune response


    T cell competition

    When cells start to become cancerous, they begin to produce mutant proteins that are not seen in healthy cells


    Eventually, these T cells will experience a phenomenon called "T cell exhaustion", which occurs when the tumor creates an immunosuppressive environment that makes the T cells lose their function and causes the tumor to grow uncontrollably


    Scientists hope that cancer vaccines can help restore the vitality of these T cells and help them attack tumors


    Berg said: "These therapies have played an amazing role in a small number of patients, but the response of most patients is still not very good


    Previous studies have shown that only a small percentage of the hundreds of neoantigens found in most tumors can produce T cell responses


    This new MIT study helps explain why this happens


    However, Burger found that if she vaccinated these mice with neoantigens targeted by suppressed T cells, she could rejuvenate these T cell populations


    She said: "If you vaccinate against an antigen that suppresses the response, you can release these T cell responses


    Reduce tumors

    In this study, the researchers found that when they were vaccinated with neoantigen vaccines, the success rate was highest, and the neoantigens were weakly bound to immune cells responsible for submitting antigens to T cells


    Berg said: "The more T cells proliferate, they can better target tumors


    After vaccination, the T cell population includes a cell with the potential to continue to supplement the response, which may allow the tumor to be controlled for a long time


    In future work, the researchers hope to test treatments that combine this vaccination strategy with cancer drugs called checkpoint inhibitors, which can stop tired T cells from working and stimulate them to attack tumors
    .
    The findings published today support this view.
    The findings also show that vaccination increases the number of a specific type of T cell that has been shown to respond well to checkpoint therapy
    .

    references:

    Megan L.
    Burger, Amanda M.
    Cruz, Grace E.
    Crossland, Giorgio Gaglia, Cecily C.
    Ritch, Sarah E.
    Blatt, Arjun Bhutkar, David Canner, Tamina Kienka, Sara Z.
    Tavana, Alexia L.
    Barandiaran, Andrea Garmilla, Jason M.
    Schenkel, Michelle Hillman, Izumi de los Rios Kobara, Amy Li, Alex M.
    Jaeger, William L.
    Hwang, Peter MK Westcott, Michael P.
    Manos, Marta M.
    Holovatska, F.
    Stephen Hodi, Aviv Regev, Sandro Santagata and Tyler Jacks, September 16, 2021, Cell
    .
    DOI: 10.
    1016 / j.
    cell.
    2021.
    08.
    020

    MIT research discovers new targets for future cancer vaccines



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.